Summit Therapeutics Inc.

SMMTNASDAQHealthcare● Active

$14.40

$-0.38(-2.54%)

Market Cap$11.2B

P/E Ratio—

52W High$30.98

52W Low$13.83

Avg Volume4.1M

Open$14.94

Beta-1.31

Cash on Hand Financials Revenue

Summit Therapeutics Inc. (SMMT) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

SMMT · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$529.5M▲ +60.7% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$167.2M

cashAndCashEquivalents

Short-Term Investments

$362.3M

shortTermInvestments

YoY Change vs Prior Year

+60.7%

vs prior fiscal year

Latest Quarter

$454.1M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$529.5MCash on Hand

Total Debt$15.5MTotal Debt

Net Cash / Net Debt+$514.0MNet Cash Position

Cash vs Debt Ratio

Cash 97%Summit Therapeutics Inc. cash as % of market cap: 4.74%% · MCap $11BDebt 3%

Summit Therapeutics Inc. has a net cash position of $514.0M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$529.5M − $15.5M = +$514.0M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

SMMT annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

SMMT cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$529.5M+60.7%

Dec 31, 2024FY$329.5M+123.6%

Dec 31, 2023FY$147.4M-48.1%

Dec 31, 2022FY$284.2M+434.0%

Dec 31, 2021FY$53.2M+9.1%

SMMT cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

SMMT vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Summit Therapeutics Inc.YOU

SMMT

$529.5M$11B4.7%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Summit Therapeutics Inc. (SMMT) cash on hand as of December 31, 2025 is $529.5M, comprising $167.2M in cash and cash equivalents (CCE) plus $362.3M in short-term investments — reported as Summit Therapeutics Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Summit Therapeutics Inc. cash reserves or cash position.

Summit Therapeutics Inc. annual cash on hand history shows increased +60.7% in 2025: increased +60.7% in 2025. Summit Therapeutics Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Summit Therapeutics Inc. carries total debt of $15.5M against cash of $529.5M, resulting in a net cash position of +$514.0M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

SMMT cash on hand · 5 questions

As of December 31, 2025, Summit Therapeutics Inc. (SMMT) has $529,492,567 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $167,183,414 in cash and cash equivalents (CCE) plus $362,309,153 in short-term investments. Latest quarter (March 31, 2026): $454,053,641. Data sourced from the annual 10-K filing via FMP.

SMMT cash on handSMMT cash reservesSMMT cash 2025how much cash does SMMT have

▸ Source: FMP /balance-sheet-statement · US GAAP · Summit Therapeutics Inc. · Summit Therapeutics Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025